lymphotoxin beta receptor-dependent control lipid homeostasis 
hyperlipidemia one important risk factors coronary heart disease often associated inflammation identified lymphotoxin lt light tumor necrosis factor cytokine family members primarily expressed lymphocytes critical regulators key enzymes control lipid metabolism dysregulation light expression t cells resulted hypertriglyceridemia hypercholesterolemia low-density lipoprotein receptor-deficient mice lack ability control lipid levels blood inhibition lt light signaling soluble lymphotoxin beta receptor decoy protein attenuated dyslipidemia results suggest immune system directly influences lipid metabolism lt modulating agents may represent novel therapeutic route treatment dyslipidemia 
